• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过腔静脉瓣膜植入进行经导管三尖瓣反流治疗——中心静脉位置去细胞组织瓣膜的实验评估

Transcatheter treatment of tricuspid regurgitation by caval valve implantation--experimental evaluation of decellularized tissue valves in central venous position.

作者信息

Lauten Alexander, Laube Adrian, Schubert Harald, Bischoff Sabine, Nietzsche Sandor, Horstkötter Kim, Poudel-Bochmann Bhawana, Franz Marcus, Lichtenberg Artur, Figulla Hans R, Akhyari Payam

机构信息

Department of Internal Medicine I (Cardiology, Angiology, Pneumology, Intensive Care Medicine), University Heart Center, Friedrich-Schiller-University, Jena, Germany.

出版信息

Catheter Cardiovasc Interv. 2015 Jan 1;85(1):150-60. doi: 10.1002/ccd.25380. Epub 2014 Feb 1.

DOI:10.1002/ccd.25380
PMID:24403276
Abstract

BACKGROUND

Caval valve implantation has been suggested for transcatheter treatment of severe tricuspid regurgitation (TR). Combining the interventional technique with the promising surgical experience with decellularized valves, we sought to evaluate the functional and structural outcome of decellularized pericardial tissue valves (dTVs) in the low-pressure venous circulation in a chronic model of TR.

METHODS AND RESULTS

Sixteen pericardial tissue valves were heterotopically implanted in the inferior and superior vena cava in a sheep model (54-98 kg; median 74.5 kg, n = 8) of severe TR. The devices were assembled using self-expanding nitinol stents and bovine pericardia decellularized by a detergent-based protocol (group dTV; n = 8). Glutaraldehyde-fixed pericardial tissue valves served as control (GaTV, n = 8). After 6 months, device function and structural maturation were analyzed using echocardiographic, histologic, immunohistologic, and electron microscopic approaches. After implantation, cardiac output increased significantly from 3.7 ± 1.1 l/min to 4.8 ± 1.1 l/min (P < 0.05) and competent valve function was verified by angiography. At 6 months, angiographic and echocardiographic evaluation revealed moderate to severe regurgitation in all GaTV. In contrast, five of the eight dTVs functioned well with only minor regurgitation. In these animals, autopsy revealed preserved valve structure with tender leaflets without signs of thrombosis or calcification. Conversely, GaTV showed severe degeneration with large calcification areas. Microscopic and histologic analysis confirmed endothelial repopulation in both valve types. However, additional interstitial reseeding was observed in decellularized valves.

CONCLUSIONS

In the venous circulation in severe TR, decellularized valves show superior functional performance compared to Ga-fixed tissue valves. Macroscopic and microscopic analyses suggest preserved structural integrity and advanced endothelial and interstitial repopulation with evidence of less degradation in dTV. © 2014 Wiley Periodicals, Inc.

摘要

背景

有人提出采用腔静脉瓣植入术经导管治疗严重三尖瓣反流(TR)。我们将介入技术与脱细胞瓣膜的成功手术经验相结合,试图在TR慢性模型的低压静脉循环中评估脱细胞心包组织瓣膜(dTV)的功能和结构转归。

方法与结果

在严重TR的绵羊模型(体重54 - 98千克;中位数74.5千克,n = 8)的下腔静脉和上腔静脉中异位植入16个心包组织瓣膜。这些装置使用自膨胀镍钛诺支架和经基于去污剂方案脱细胞的牛心包组装而成(dTV组;n = 8)。戊二醛固定的心包组织瓣膜作为对照(GaTV,n = 8)。6个月后,采用超声心动图、组织学、免疫组织学和电子显微镜方法分析装置功能和结构成熟情况。植入后,心输出量从3.7±1.1升/分钟显著增加至4.8±1.1升/分钟(P < 0.05),血管造影证实瓣膜功能良好。6个月时,血管造影和超声心动图评估显示所有GaTV均有中度至重度反流。相比之下,8个dTV中有5个功能良好,仅有轻微反流。在这些动物中,尸检显示瓣膜结构保存完好,瓣叶柔软,无血栓形成或钙化迹象。相反,GaTV显示严重退变,有大片钙化区域。显微镜和组织学分析证实两种瓣膜类型均有内皮细胞重新生长。然而,在脱细胞瓣膜中观察到额外的心间质再植入。

结论

在严重TR的静脉循环中,脱细胞瓣膜与戊二醛固定的组织瓣膜相比,具有更好的功能表现。宏观和微观分析表明,dTV结构完整性得以保留,内皮细胞和心间质重新生长进展良好,且降解程度较轻。© 2014威利期刊公司。

相似文献

1
Transcatheter treatment of tricuspid regurgitation by caval valve implantation--experimental evaluation of decellularized tissue valves in central venous position.通过腔静脉瓣膜植入进行经导管三尖瓣反流治疗——中心静脉位置去细胞组织瓣膜的实验评估
Catheter Cardiovasc Interv. 2015 Jan 1;85(1):150-60. doi: 10.1002/ccd.25380. Epub 2014 Feb 1.
2
Interventional Treatment of Severe Tricuspid Regurgitation: Early Clinical Experience in a Multicenter, Observational, First-in-Man Study.介入治疗重度三尖瓣反流:多中心观察性首例人体研究的早期临床经验。
Circ Cardiovasc Interv. 2018 Feb;11(2):e006061. doi: 10.1161/CIRCINTERVENTIONS.117.006061.
3
Study design and rationale of the heterotopic implantation of the Edwards-Sapien XT transcatheter valve in the inferior VEna cava for the treatment of severe tricuspid regurgitation (HOVER) trial.爱德华兹- Sapien XT经导管瓣膜在下腔静脉异位植入治疗严重三尖瓣反流(HOVER)试验的研究设计与原理
Catheter Cardiovasc Interv. 2016 Aug;88(2):287-93. doi: 10.1002/ccd.26530. Epub 2016 Apr 28.
4
The International Multicenter TriValve Registry: Which Patients Are Undergoing Transcatheter Tricuspid Repair?国际多中心三尖瓣注册研究:哪些患者正在接受经导管三尖瓣修复?
JACC Cardiovasc Interv. 2017 Oct 9;10(19):1982-1990. doi: 10.1016/j.jcin.2017.08.011.
5
Intermediate term hemodynamic effects of single inferior vena cava valve implant for the treatment of severe tricuspid regurgitation.单一下腔静脉瓣植入治疗严重三尖瓣反流的中期血流动力学效应
Catheter Cardiovasc Interv. 2017 Sep 1;90(3):521-525. doi: 10.1002/ccd.26931. Epub 2017 Feb 7.
6
Transcatheter tricuspid valve implantation: a multicentre French study.经导管三尖瓣植入术:一项法国多中心研究。
Arch Cardiovasc Dis. 2014 Nov;107(11):583-91. doi: 10.1016/j.acvd.2014.07.051. Epub 2014 Oct 2.
7
Percutaneous caval stent valve implantation: investigation of an interventional approach for treatment of tricuspid regurgitation.经皮腔静脉支架瓣膜植入术:治疗三尖瓣反流的介入治疗方法的研究。
Eur Heart J. 2010 May;31(10):1274-81. doi: 10.1093/eurheartj/ehp474. Epub 2009 Nov 18.
8
First-in-Man Implantation of a Tricuspid Annular Remodeling Device for Functional Tricuspid Regurgitation.用于功能性三尖瓣反流的三尖瓣环重塑装置的首次人体植入。
JACC Cardiovasc Interv. 2015 Nov;8(13):e211-4. doi: 10.1016/j.jcin.2015.06.028.
9
A personalized approach to interventional treatment of tricuspid regurgitation: experiences from an acute animal study.三尖瓣反流介入治疗的个性化方法:一项急性动物研究的经验
Interact Cardiovasc Thorac Surg. 2014 Sep;19(3):414-8. doi: 10.1093/icvts/ivu143. Epub 2014 Jun 10.
10
Transvenous, antegrade Melody valve-in-valve implantation for bioprosthetic mitral and tricuspid valve dysfunction: a case series in children and adults.经静脉、顺行 Melody 瓣中瓣植入治疗生物瓣二尖瓣和三尖瓣功能障碍:一项儿童和成人病例系列研究。
JACC Cardiovasc Interv. 2013 Jun;6(6):598-605. doi: 10.1016/j.jcin.2013.02.010. Epub 2013 May 15.

引用本文的文献

1
Bacterial biofilms in infective endocarditis: an in vitro model to investigate emerging technologies of antimicrobial cardiovascular device coatings.感染性心内膜炎中的细菌生物膜:一种体外模型,用于研究新型抗菌心血管器械涂层技术。
Clin Res Cardiol. 2021 Mar;110(3):323-331. doi: 10.1007/s00392-020-01669-y. Epub 2020 May 22.
2
Transcatheter valve-in-valve implantation (VinV-TAVR) for failed surgical aortic bioprosthetic valves.经导管瓣膜内植入术(VinV-TAVR)治疗失败的外科生物瓣主动脉瓣。
Clin Res Cardiol. 2019 Jan;108(1):83-92. doi: 10.1007/s00392-018-1326-z. Epub 2018 Jul 12.
3
Customized Interface Biofunctionalization of Decellularized Extracellular Matrix: Toward Enhanced Endothelialization.
去细胞化细胞外基质的定制界面生物功能化:迈向增强内皮化
Tissue Eng Part C Methods. 2016 May;22(5):496-508. doi: 10.1089/ten.TEC.2015.0556. Epub 2016 Apr 25.
4
Current progress in tissue engineering of heart valves: multiscale problems, multiscale solutions.心脏瓣膜组织工程的当前进展:多尺度问题与多尺度解决方案
Expert Opin Biol Ther. 2015;15(8):1155-72. doi: 10.1517/14712598.2015.1051527. Epub 2015 Jun 1.
5
Percutaneous pulmonary and tricuspid valve implantations: An update.经皮肺动脉瓣和三尖瓣植入术:最新进展
World J Cardiol. 2015 Apr 26;7(4):167-77. doi: 10.4330/wjc.v7.i4.167.